Search Results - "Oldenburg, H.S.A"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer by Straver, M.E, Rutgers, E.J.Th, Russell, N.S, Oldenburg, H.S.A, Rodenhuis, S, Wesseling, J, Vincent, A, Peeters, M.T.F.D. Vrancken

    Published in European journal of cancer (1990) (01-09-2009)
    “…Abstract Aims The purpose of this study is to analyse nodal staging and axillary response in breast cancer patients treated with neoadjuvant chemotherapy (NAC)…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Breast conserving surgery for extensive DCIS using multiple radioactive seeds by Janssen, N.N.Y., van la Parra, R.F.D., Loo, C.E., Groen, E.J., van den Berg, M.J., Oldenburg, H.S.A., Nijkamp, J., Vrancken Peeters, M.T.F.D.

    Published in European journal of surgical oncology (01-01-2018)
    “…Breast conserving surgery (BCS) can be challenging for large regions of ductal carcinoma in situ (DCIS), resulting in high rates of positive resection margins…”
    Get full text
    Journal Article
  9. 9

    Simultaneous use of an 125I-seed to guide tumour excision and 99mTc-nanocolloid for sentinel node biopsy in non-palpable breast-conserving surgery by Pouw, B., van der Ploeg, I.M.C., Muller, S.H., Valdés Olmos, R.A., Janssen-Pinkse, L.K., Oldenburg, H.S.A., Vrancken Peeters, M.T.F.D.

    Published in European journal of surgical oncology (01-01-2015)
    “…In the present study we describe patients with non-palpable breast lesions, in which an Iodine-125 (125I)-marker (or “seed”) for excision of the primary tumour…”
    Get full text
    Journal Article
  10. 10

    Simultaneous use of an125 I-seed to guide tumour excision and99m Tc-nanocolloid for sentinel node biopsy in non-palpable breast-conserving surgery by Pouw, B, van der Ploeg, I.M.C, Muller, S.H, Valdés Olmos, R.A, Janssen-Pinkse, L.K, Oldenburg, H.S.A, Vrancken Peeters, M.T.F.D

    “…Abstract Purpose In the present study we describe patients with non-palpable breast lesions, in which an Iodine-125 (125 I)-marker (or “seed”) for excision of…”
    Get full text
    Journal Article
  11. 11

    Effects of Lycopene on the Insulin-Like Growth Factor (IGF) System in Premenopausal Breast Cancer Survivors and Women at High Familial Breast Cancer Risk by Voskuil, D.W, Vrieling, A, Korse, C.M, Beijnen, J.H, Bonfrer, J.M.G, Doorn, J. van, Kaas, R, Oldenburg, H.S.A, Russell, N.S, Rutgers, E.J.T

    Published in Nutrition and cancer (2008)
    “…Insulin-like growth factor-I (IGF-I) is an important growth factor associated with increased risk of premenopausal breast cancer. We conducted a randomized,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breast by Meijnen, Ph, Peterse, J.L., Oldenburg, H.S.A., Woerdeman, L.A.E., Rutgers, E.J.Th

    Published in European journal of surgical oncology (01-10-2005)
    “…The increased incidence of ductal carcinoma in situ (DCIS) of the breast and the emergence of new diagnostic and therapeutic tools like mammographic screening,…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Aortic aneurysm repair is associated with a lower inflammatory response compared with surgery for inflammatory bowel disease by Oldenburg, H S A, Siroen, M P C, Boelens, P G, Sluijter, B J R, Pruitt, J H, Naseri, A H, Rauwerda, J A, Meijer, S, Cuesta, M A, van Leeuwen, P A M, Moldawer, L L

    Published in European surgical research (01-09-2004)
    “…Since the plasma cytokine profile reflects the body's inflammatory response to injury, this study was designed to prospectively observe the plasma cytokine…”
    Get more information
    Journal Article